首页> 美国卫生研究院文献>Canadian Medical Association Journal >Womens decisions about hormone replacement therapy after education and bone densitometry
【2h】

Womens decisions about hormone replacement therapy after education and bone densitometry

机译:妇女关于接受教育和骨密度测定后激素替代疗法的决定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BACKGROUND: The decisions that postmenopausal women make about whether to start hormone replacement therapy may depend on the potential risks and benefits of such therapy as well as their risk for osteoporosis-related fractures. This study examined the decisions made by women at risk for osteoporosis-related fractures who were educated about hormone replacement therapy and who were given information about their bone mineral density. METHODS: The study employed a prospective cohort design. Thirty-seven post--menopausal women with risk factors for osteoporosis-related fractures were recruited from an orthopedic clinic at a teaching hospital in Hamilton, Ont. The women were given an education kit (consisting of an audio tape and a work-book) to clarify the benefits and risks of hormone replacement therapy. Two to 4 weeks later, densitometry of the hip and the lumbar spine was performed. A summary of the risks, the densitometry findings and decisions about hormone replacement therapy were given to the women's family physicians for follow-up. Outcome measures included decisions about hormone replacement therapy, as well as use of such therapy and other medications at 12 months. RESULTS: After the education component alone, 10 (27%) of the women requested hormone replacement therapy. After densitometry testing, 4 more requested hormone replacement therapy (for a total of 14 women [38%]). At 12 months, 2 (5%) of the women had been lost to follow-up. Of the remaining 35, 6 (17%) were receiving hormone replacement therapy, 7 (20%) were using bisphosphonates, and 24 (68%) were taking calcium supplements. INTERPRETATION: These preliminary findings suggest that the combination of education about hormone therapy and feedback about bone density is associated with an increase in the use of hormone replacement therapy and other preventive medications by women at risk for osteoporosis-related fractures. However, the observed increase was small and so the clinical significance must be confirmed and clarified.
机译:背景:绝经后妇女是否开始激素替代治疗的决定可能取决于这种治疗的潜在风险和益处,以及她们发生骨质疏松症相关骨折的风险。这项研究调查了有骨质疏松症相关骨折风险的妇女所做出的决定,这些妇女接受过激素替代疗法的教育,并获得了有关其骨矿物质密度的信息。方法:本研究采用前瞻性队列设计。从安大略省汉密尔顿市一家教学医院的整形外科诊所招募了37名患有骨质疏松相关骨折危险因素的绝经后妇女。为妇女提供了一个教育工具包(包括录音带和工作簿),以阐明激素替代疗法的益处和风险。 2至4周后,进行臀部和腰椎的密度测定。风险摘要,光密度测定结果和有关激素替代疗法的决定已交给女性家庭医生进行随访。结果措施包括有关激素替代疗法的决策,以及在12个月时使用此类疗法和其他药物的决定。结果:仅在接受教育之后,有10名(27%)妇女要求激素替代治疗。在光密度测定法测试之后,又有4位患者要求激素替代治疗(共14位女性[38%])。在12个月时,有2名(5%)妇女失去了随访。其余35名患者中,有6名(17%)正在接受激素替代治疗,其中7名(20%)正在使用双膦酸盐,而24名(68%)正在服用钙补充剂。解释:这些初步发现表明,对激素治疗的教育与对骨密度的反馈相结合,可以增加患有骨质疏松症相关骨折风险的女性对激素替代疗法和其他预防药物的使用。但是,观察到的增加很小,因此必须确认和阐明其临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号